Patent extensions are crucial for pharmaceutical companies as they provide additional years of market exclusivity beyond the original patent term. This directly impacts the company's ability to generate revenue from the drug without competition from generic versions. For Esperion, this extension for Bempedoic Acid, a key product in its portfolio, is likely to have a positive impact on its stock price in the short term as it reassures investors of sustained revenue potential.